Retrospective Study
Copyright ©The Author(s) 2020.
World J Gastroenterol. Jul 28, 2020; 26(28): 4126-4139
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4126
Table 2 Histopathologic features of Primary sclerosing cholangitis-Ulcerative colitis and Primary sclerosing cholangitis-Crohn disease patients, n (%)
PSC-UC1UC1P valuePSC-CD1CD1P valueP value (PSC-UC vs PSC-CD)
Distribution of disease
Right colon only7 (29)1 (4)0.03a3 (50)2 (33)0.60.3
Left colon only1 (4)7 (26)0.060010.9
Left and right colon16 (67)17 (63)0.83 (50)4 (67)0.60.4
Rectum15 (68)18 (90)0.11 (20)5 (83)0.0550.07
Ileitis4 (31)1 (7)0.15 (100)4 (67)0.90.9
Severity of disease (active inflammation)
Right colon (average activity score)1.250.960.21.510.30.5
Left colon (average activity score)1.21.820.03a0.830.860.90.4
Rectum (average activity score)0.962.050.0006a0.21.170.10.1
Ileum (average activity score)0.310.070.21110.01a
Max average activity score at any site1.462.290.0005a1.831.670.70.3
Architectural distortion
Right colon24 (100)21 (78)0.96 (100)6 (100)11
Left colon24 (96)26 (93)0.66 (100)7 (100)10.9
Rectum18 (78)19 (95)0.15 (100)5 (83)0.90.9
Any site26 (100)28(100)16 (100)9 (100)11
Paneth cell metaplasia
Left colon11 (44)14 (50)0.71 (17)4 (57)0.10.2
Rectum5 (22)6 (30)0.51 (20)00.90.9
Basal plasmacytosis
Right colon14 (58)13 (48)0.52 (33)3 (50)0.50.3
Left colon11 (44)22 (79)0.01a04 (57)0.90.9
Rectum6 (26)19 (95)0.0004a1 (20)3 (50)0.30.7
Any site16 (62)27 (96)0.01a3 (50)7 (78)0.20.6
Pyloric gland metaplasia
Right colon2 (8)1 (4)0.71 (17)1 (17)10.6
Left colon0010011
Any site2 (8)1 (4)0.51 (17)1 (11)0.70.5
Granulomas
Any site1 (4)00.91 (17)6 (67)0.080.3